Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
14,472 total articles
Hilton (HLT) looks buyable after consistent revenue and RevPAR momentum, a $2.03B trailing free cash flow run-rate and a manageable valuation when judged by enterprise metrics. Technicals show near-term weakness, which creates an attractive entry point. This trade proposes a long with a $350 target and a $290 stop, horizon of long term (180 trading…
HPE just delivered another quarter of outperformance, and the setup now favors a mid-term swing trade. The company combines direct AI/data-center exposure, improving networking via the Juniper deal, and healthy free cash flow against a valuation that looks reasonable if growth sustains. I lay out an entry, stop, and target with a clear 45-trading-d…
Marvell has re-emerged as a frontline supplier to hyperscalers and optical connectivity vendors. Strong Q3 revenue acceleration, large AI bookings, and international exposure underpin a bullish mid-term trade. Valuation is rich, so this idea uses a defined entry, stop and layered targets to capture upside while limiting downside.
Nature's Sunshine Products (NATR) looks set for a tactical bounce after a sharp pullback. The company's low valuation (EV/EBITDA ~3.9, P/E ~14) and solid cash generation (free cash flow $18.11M) cushion downside, while new commercial hires and product recognition create practical near-term catalysts. We lay out an actionable mid-term long with entr…
UMB Financial (UMBF) reported strong Q2 results, accelerated loan and deposit growth from the Heartland acquisition, and is showing measurable efficiency gains. With a market cap near $10.8B, cheap multiples and a conservative balance sheet, UMB presents a tactical long trade for investors willing to hold through near-term volatility.
ServiceNow (NOW) has ripped higher on AI optimism, but the stock trades at a steep multiple against mixed volume and intensifying competition from Microsoft and Salesforce. We lay out a mid-term (45 trading days) short with a clear entry at $145.21, a $158 stop, and a $120 target—a trade that plays for mean reversion as growth expectations get re-p…
Vertiv is priced like a high-growth industrial. With EPS of $4.50, a market cap near $99B and a rapidly expanding AI-driven backlog, I think a 38x forward P/E is a defensible valuation if execution holds. This trade plan buys into that convergence: entry at $256.70, target $304.00 and a stop at $220.00 over a mid-term (45 trading days) horizon.
ImmunityBio ($IBRX) is a clinically focused immunotherapy company with an accepted sBLA for ANKTIVA and multiple pipeline programs. The stock is trading around $7.98 after heavy headlines and litigation noise, but the market is not fully accounting for a positive PDUFA outcome and commercial upside. This trade targets a material re-rating into $18 …
Sandisk’s multiyear supply agreements with price floors and ceilings have materially changed the NAND economics for the industry. That structural shift reduces the odds of a sharp memory-price crash and lifts the secular case for capacity-hungry players. Western Digital (WDC) still stands to benefit from AI-driven storage demand and trades at rough…
Enliven Therapeutics (ELVN) has priced a high-conviction growth story into a $4.4B market cap: ELVN-001 is a clean, active-site BCR-ABL kinase inhibitor that, if confirmed in later-stage data, can change chronic myeloid leukemia (CML) sequencing. The stock trades near $59.78 with a heavy short-interest backdrop and supportive technicals. This trade…
NIO is trading below $4 with accelerating deliveries, expanding battery-swap infrastructure, and technicals that suggest capitulation. With a market cap under $10B and unit volumes rising, this trade targets a rebound as margins improve and losses shrink — while respecting execution and macro risks.
Alphabet is trading at a reasonable multiple while its businesses - led by Google Cloud and advertising - are benefitting from a large, accelerating AI spend cycle. This trade idea buys a near-term pullback and holds into the next leg of AI monetization: entry $342.05, stop $318.00, target $400.00 over a position horizon (180 trading days).
Uniti Group (UNIT) is trading at compelling headline multiples relative to its asset base and recent operational momentum. With recent fiber securitizations, an upsized senior notes placement and continued Kinetic network rollouts, there are several near-term catalysts that could re-rate the stock. This trade idea lays out a mid-term (45 trading da…
SAP recovered sharply from its July low and has retraced much of the downside. Technicals now show weakening momentum even as valuation sits near $268B market cap. I’m downgrading my stance and putting on a mid‑term short trade: entry $218.00, target $195.00, stop $231.00 (45 trading days).
Micron’s fundamentals and cash-generation profile argue that AI and hyperscale memory demand are not fully priced in. With strong free cash flow, low leverage, and improving technical momentum, this trade targets $1,250 over a 180-trading-day horizon. Entry $940.00, stop $820.00.
TTM Technologies (TTMI) is trading well off its 52-week high after a sharp, sentiment-driven pullback. Fundamentals remain intact: strong revenue growth tied to data-center and networking demand, improving profitability, a healthy balance sheet and an accretive European acquisition that should diversify end markets. Technicals show short-term pain …
Alcon ($ALC) offers a tactical long setup around $71.63. The company sits in a structurally growing ophthalmology market, trades below its 52-week high, and exhibits solid balance-sheet metrics that reduce downside risk. Combined with outsized short interest and recent institutional buying, there’s a credible path to a re-rating over the next 45 tr…
Monte Rosa Therapeutics (GLUE) trades around $14.27 with a market cap near $1.21B. The stock combines high clinical binary risk with a clean balance sheet after a $300M raise and a $120M upfront collaboration with Novartis. For disciplined traders willing to stomach biotech volatility, a long position sized carefully offers compelling asymmetric up…
Broadcom (AVGO) is a hybrid semiconductor-software cash machine that the market is currently valuing at roughly 19x 2027 earnings. That multiple understates the company’s recurring software margin profile, cash generation and buyback optionality. We recommend a long trade with a clear entry, stop and target tied to improving fundamentals and multip…
CoreWeave's interest expense running at roughly four times its operating income is a headline-grabber. It matters, but it is not the primary variable that will move the stock near-term. This trade idea buys the leverage to the AI compute cycle while protecting against refinancing and demand risks with a strict stop. Entry, targets and timeframe are…
Rocket Companies (RKT) is showing early signs that its partner-network strategy and mortgage servicing additions are stabilizing earnings. With shares around $13.99 and a market cap near $28.5B, the risk/reward favors a controlled long trade into an operational and housing-cycle recovery. This idea pairs a tactical entry with disciplined stops give…
Expand Energy (EXE) trades like a well-funded natural gas operator: low leverage, healthy free cash flow and a single-digit P/E. The near-term trade is to establish a long position around $99.34 while buying protection to limit downside over the next 10 trading days, then hold for up to 180 trading days to capture upside from LNG export and higher …
Medtronic's Diabetes (MiniMed) business is reaccelerating and driving recurring revenue growth. Q1 showed $9.76B in revenue (+13.7% YoY) and outperformance across cardiovascular and diabetes, supporting a swing trade long. Valuation sits at ~ $118B market cap with a 3.1% yield and healthy free cash flow. Trade plan: enter $92.50, target $105.00, st…
Metallium is a small-cap recycler focused on extracting gold, silver and PGMs from e-waste using a modular recovery approach. With rising e-waste volumes and tightened sourcing of secondary metals, the company could see accelerating revenue if pilots scale. This trade idea takes a conditional long: enter at $1.25, target $3.50, stop $0.90, horizon …
EWT (iShares MSCI Taiwan ETF) offers direct exposure to the AI hardware supply chain that is driving incremental capital spending in Taiwan. Technicals are constructive, valuation is reasonable for an ETF focused on tech-heavy Taiwan, and yields are modest. However, elevated geopolitical risk tied to cross-strait tensions - including scenarios that…
